| Literature DB >> 27611903 |
Felipe B Schuch1,2, Davy Vancampfort3,4, Simon Rosenbaum5,6, Justin Richards7, Philip B Ward5,6, Nicola Veronese8, Marco Solmi9, Eduardo L Cadore10, Brendon Stubbs11,12.
Abstract
OBJECTIVE: To evaluate the antidepressant effects of exercise in older adults, using randomized controlled trial (RCT) data.Entities:
Mesh:
Year: 2016 PMID: 27611903 PMCID: PMC7194268 DOI: 10.1590/1516-4446-2016-1915
Source DB: PubMed Journal: Braz J Psychiatry ISSN: 1516-4446 Impact factor: 2.697
Figure 1Flowchart of study selection.
Summary of included studies
| Study | Sample size (n) | Age (mean or range) | Sex (% female) | Antidepressant use (% taking) | Outcome | Trial duration (weeks) | Diagnosis | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Exercise | Control | Exercise | Control | Exercise | Control | Exercise | Control | ||||
| Brenes | 14 | 12 | 73.5 | 73.9 | 64 | 50 | 0 | 0 | HAM-D | 16 | Depressive symptoms |
| Huang | 19 | 20 | 76.42 | 75.85 | 57.9 | 55 | 0 | 0 | GDS-15 | 12 | Depressive symptoms |
| McNeil | 10 | 10 | ? | ? | ? | ? | 0 | 0 | BDI | 6 | Depressive symptoms |
| Shahidi | 20 | 20 | 65.7 | 68.4 | 100 | 100 | ? | ? | GDS | ? | Depressive symptoms |
| Sims | 23 | 21 | 67.95 | 66.27 | 39 | 41 | ? | ? | PHQ-9 | 10 | Depressive symptoms |
| Singh | 17 | 15 | 70 | 72 | 70.5 | 53.3 | 0 | 0 | BDI | 10 | MDD + dysthymia |
| Singh | 18 | 19 | 69 | 69 | 55 | 50 | 0 | 42 | HAM-D | 8 | MDD + dysthymia |
| Williams & Tappen | 17 | 12 | 71-101 | 71-101 | ? | ? | ? | ? | CSDD | 16 | Depressive symptoms |
BDI = Beck Depression Inventory; CSDD = Cornell Scale for Depression in Dementia; GDS = Geriatric Depression Scale; HAM-D = Hamilton Depression Scale; MDD = major depressive disorder; PHQ-9 = Patient Health Questionnaire.
Figure 2Meta-analysis of all included studies. 95%CI = 95% confidence interval; SE = standard error; SMD = standardized mean difference.
Subgroup meta-analysis of all studies
| Analysis | RCTs (n) | SMD | 95%CI | p-value | Heterogeneity (I2) | Trim and fill effect size (95%CI, adjusted studies) | Fail-safe number (n) |
|---|---|---|---|---|---|---|---|
| Main analysis | |||||||
| Exercise vs. control | 8 | -0.900 | -0.29 to -1.51 |
| 81.63 | Unchanged | 71 |
| Depression classification | |||||||
| MDD/dysthymia/MiDD | 2 | -1.883 | 0.44 to -4.21 | 0.11 | 93.06 | N/A | N/A |
| Depressive symptoms | 6 | -0.560 | -0.14 to -0.97 |
| 61.00 | Unchanged | 26 |
| Study setting | |||||||
| Outpatient/community | 7 | -1.037 | -0.37 to -1.74 |
| 82.33 | Unchanged | 73 |
| Nursing homes | 1 | -0.022 | 0.71 to -0.76 | 0.953 | 0 | N/A | N/A |
| Intensity of exercise | |||||||
| Moderate | 1 | -0.73 | 0.08 to -1.38 |
| 0 | N/A | N/A |
| Vigorous | 3 | -1.15 | 0.50 to -2.80 | 0.17 | 93.47 | Unchanged | 11 |
| Exercise type | |||||||
| Aerobic only | 3 | -0.66 | -0.10 to -1.42 | 0.09 | 65.82 | Unchanged | 4 |
| Resistance only | 3 | -1.15 | 0.50 to -2.80 | 0.174 | 93.40 | Unchanged | 11 |
| Mixed | 2 | -0.92 | -0.41 to -1.43 |
| 0 | N/A | N/A |
| Group exercise | |||||||
| Yes | 6 | -0.97 | -0.24 to -1.71 |
| 84.35 | -1.24 (0.38-2.10) (1) | 49 |
| No | 2 | -0.69 | 0.78 to -2.36 | 0.356 | 82.49 | N/A | N/A |
| Supervision | |||||||
| Supervised | 6 | -0.86 | -0.07 to -1.66 |
| 85.19 | -1.11 (0.24-1.98) (1) | 34 |
| Supervised and unsupervised | 1 | -1.48 | -0.49 to -2.47 |
| 0 | N/A | N/A |
| Comorbidities | |||||||
| No major comorbidities | 6 | -1.25 | -0.62 to -1.87 |
| 74.10 | -1.38 (0.78-1.99) (1) | 81 |
| Participants with comorbidities | 2 | -0.14 | 0.61 to -0.31 | 0.52 | 0 | N/A | N/A |
95%CI = 95% confidence interval; MDD = major depressive disorder; MiDD = minor depressive disorder; N/A = not available; RCTs = randomized clinical trials; SMD = standardized mean difference.
Values in bold are significant.
Meta-regression of moderators/correlates of effects of exercise on depression
| Moderator | RCTs (n) | β | 95%CI | p-value | R2 |
|---|---|---|---|---|---|
| Mean age, control | 6 | 0.122 | -0.083 to 0.327 | 0.24 | 0.02 |
| Mean age, exercise | 6 | 0.049 | -0.209 to 0.308 | 0.70 | 0.00 |
| Females, exercise (%) | 6 | 0.017 | -0.020 to 0.058 | 0.40 | 0.00 |
| Females, control (%) | 6 | 0.005 | -0.042 to 0.042 | 0.99 | 0.00 |
| Baseline depressive symptoms, exercise | 8 | 0.156 | 0.008 to 0.3223 | 0.06 | 0.09 |
| Baseline depressive symptoms, control | 8 | -0.021 | -0.150 to 0.107 | 0.74 | 0.00 |
| Dropout, exercise (%) | 7 | -0.050 | -0.195 to 0.095 | 0.49 | 0.28 |
| Dropout, control (%) | 7 | -0.058 | -0.168 to 0.052 | 0.30 | 0.00 |
| Trial duration | 7 | -0.017 | -0.209 to 0.173 | 0.85 | 0.00 |
| Weekly intervention frequency | 7 | -0.524 | -1.268 to 0.219 | 0.16 | 0.00 |
95%CI = 95% confidence interval; RCTs = randomized clinical trials.